Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,953 | 125,158 | 135,821 | 183,186 | 150,031 |
| Marketable Securities | 284,723 | 268,984 | 252,443 | 306,672 | 339,320 |
| Receivables | 41,864 | 36,713 | 34,155 | 29,272 | 33,621 |
| Inventories | 1,469 | 1,505 | 1,357 | 1,006 | 1,080 |
| TOTAL | $439,180 | $439,425 | $432,946 | $536,572 | $533,504 |
| Non-Current Assets | |||||
| PPE Net | 2,303 | 2,306 | 2,037 | 2,128 | 2,164 |
| Intangibles | 117,599 | 119,351 | 121,369 | 17,428 | 17,808 |
| Other Non-Current Assets | 92,289 | 91,600 | 92,088 | 85,477 | 88,206 |
| TOTAL | $212,191 | $213,257 | $215,494 | $105,033 | $108,178 |
| Total Assets | $651,371 | $652,682 | $648,440 | $641,605 | $641,682 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,598 | 37,773 | 38,460 | 32,595 | 31,929 |
| Other current liabilities | 54,193 | 55,569 | 49,237 | 52,242 | 55,468 |
| TOTAL | $93,791 | $93,342 | $87,697 | $84,837 | $87,397 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15,064 | 15,345 | 15,833 | 13,668 | 14,387 |
| TOTAL | $15,064 | $15,345 | $15,833 | $13,668 | $14,387 |
| Total Liabilities | $108,855 | $108,687 | $103,530 | $98,505 | $101,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,290 | 58,198 | 57,538 | 57,532 | 57,509 |
| Common Shares | 58 | 58 | 58 | 58 | 57 |
| Retained earnings | -164,056 | -159,538 | -155,392 | -152,992 | -153,129 |
| Other shareholders' equity | -330 | -383 | -30 | -967 | -865 |
| TOTAL | $542,516 | $543,995 | $544,910 | $543,100 | $539,898 |
| Total Liabilities And Equity | $651,371 | $652,682 | $648,440 | $641,605 | $641,682 |